Michael Bertram

Mike Bertram is the Controller of Strand Therapeutics and has over 15 years of accounting and finance experience. Prior to joining Strand, Mike was the Controller of Viela Bio, a public biotechnology company which was acquired by Horizon Therapeutics for $3 billion in 2021, and Senseonics, a public medical technology company. Prior to joining Senseonics, Mike worked for PricewaterhouseCoopers in the assurance practice serving clients in various industries, specifically life sciences, healthcare, and venture capital. Mike received his B.S. in Accounting from the Robert H. Smith School of Business at the University of Maryland.